Download AACR Journals: Simultaneous Publication Options Cancer

AACR Journals: Simultaneous Publication Options





Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in
research and clinical trials. As the premier cancer information resource, the Journal also presents
Review Articles, Perspectives and Commentaries, News stories, and Research Watch summaries of
important journal articles to its readers to keep them informed about the latest findings in the field.
Topics span the spectrum of cancer research and medicine from the laboratory to the clinic and
epidemiologic studies.
Current Impact Factor: 19.783
Published Daily Online; Monthly in Print
Editorial Board
Editors-in-Chief: Lewis C. Cantley and José Baselga
About the Journal





Cancer Immunology Research publishes outstanding original articles reporting major advances in
cancer immunology that span the discipline from basic investigations in host-tumor interactions to
developmental therapeutics in model systems, early translational studies in patients, and late-stage
clinical trials. The journal disseminates knowledge of immunology to the cancer research community,
catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship,
more potent cancer treatments, and improved clinical outcomes.
Papers are stringently reviewed, and specific topics of interest include endogenous antitumor
immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy,
cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment,
emerging technologies, and clinical investigations. The journal's special features include "Masters of
Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—
perspectives that highlight the intersection of immunology with other areas of cancer research and
allied disciplines.
Current Impact Factor: 6.665
Published Daily Online; Monthly in Print
Editorial Board
Editors-in-Chief: Robert D. Schreiber and Philip D. Greenberg
About the Journal





Clinical Cancer Research — A Journal of Clinical and Translational Research — focuses on
innovative clinical research and translational research that bridges the laboratory and the clinic.
Clinical Cancer Research presents clinical trials evaluating new treatments for cancer; research on
molecular abnormalities that predict incidence, response to therapy, and outcome; and laboratory
studies of new drugs and biomarkers that will lead to clinical trials in patients.
Current Impact Factor: 8.738
Published Daily Online; Semi Monthly in print
Editorial Board
Editor-in-Chief: Kenneth C. Anderson
About the Journal





Molecular Cancer Therapeutics — Integrating Targets, Therapeutics, and Technologies — strives
to be the top choice for publishing the best science in the discovery and preclinical development of
novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of
drug action, mechanisms of drug resistance, biomarkers of drug response, novel models and
technologies, and occasional drug toxicity mechanisms. While the Journal's main focus is on small
molecule and protein drugs, other molecular entities may be considered.
Current Impact Factor: 5.579
Published Daily Online; Monthly in print
Editorial Board
Editor-in-Chief: Napoleone Ferrara
About the Journal
»» Submit a Manuscript to Molecular Cancer Therapeutics